Published in Bioorg Med Chem on June 01, 1998
Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists. Naunyn Schmiedebergs Arch Pharmacol (2007) 1.02
Xanthines as adenosine receptor antagonists. Handb Exp Pharmacol (2011) 0.96
Adenosine A2A receptors in the nucleus accumbens bi-directionally alter cocaine seeking in rats. Neuropsychopharmacology (2011) 0.90
Stimulation of adenosine receptors in the nucleus accumbens reverses the expression of cocaine sensitization and cross-sensitization to dopamine D2 receptors in rats. Neuropharmacology (2012) 0.81
Purinergic A2b Receptor Activation by Extracellular Cues Affects Positioning of the Centrosome and Nucleus and Causes Reduced Cell Migration. J Biol Chem (2016) 0.75
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev (2001) 9.90
8-Cyclopentyl-1,3-dipropylxanthine (DPCPX)--a selective high affinity antagonist radioligand for A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.99
2-Chloro-N6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.47
Synthesis of new delta 2-isoxazoline derivatives and their pharmacological characterization as beta-adrenergic receptor antagonists. Bioorg Med Chem (1998) 1.39
Agonist photoaffinity labeling of A1 adenosine receptors: persistent activation reveals spare receptors. Mol Pharmacol (1986) 1.17
Adenosine receptors and cancer. Handb Exp Pharmacol (2009) 1.14
[(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. Mol Pharmacol (2000) 1.12
Photoaffinity labeling of A1-adenosine receptors. J Biol Chem (1985) 1.11
Separation of solubilized A2 adenosine receptors of human platelets from non-receptor [3H]NECA binding sites by gel filtration. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.06
Activation of the A3 adenosine receptor affects cell cycle progression and cell growth. Naunyn Schmiedebergs Arch Pharmacol (2000) 1.02
Functional molecular complexes of human N-formyl chemoattractant receptors and actin. J Immunol (1993) 0.96
Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression. J Neurosci (1997) 0.95
Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists. J Med Chem (2000) 0.94
Decreased gene expression of 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia. J Clin Endocrinol Metab (2001) 0.94
2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors. J Med Chem (1992) 0.93
Agonist-induced internalization and recycling of the human A(3) adenosine receptors: role in receptor desensitization and resensitization. J Neurochem (2000) 0.92
2',3'-Dideoxy-N6-cyclohexyladenosine: an adenosine derivative with antagonist properties at adenosine receptors. Eur J Pharmacol (1988) 0.91
Cytoskeletal regulation of chemotactic receptors: molecular complexation of N-formyl peptide receptors with G proteins and actin. Eur J Haematol (1993) 0.91
Evidence for an A2 adenosine receptor in guinea pig lung. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.91
Adenosine receptor agonists: synthesis and biological evaluation of 1-deaza analogues of adenosine derivatives. J Med Chem (1988) 0.90
Characterization of the solubilized A1 adenosine receptor from rat brain membranes. J Neurochem (1986) 0.90
Bioactive pyridoacridine alkaloids from the micronesian sponge Oceanapia sp. J Nat Prod (1998) 0.90
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen. J Med Chem (2000) 0.89
High-affinity binding and lack of growth-promoting activity of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) in a human epidermal cell line. J Invest Dermatol (1990) 0.89
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists. J Med Chem (1999) 0.89
Reconstitution of a physical complex between the N-formyl chemotactic peptide receptor and G protein. Inhibition by pertussis toxin-catalyzed ADP ribosylation. J Biol Chem (1992) 0.89
New substituted 9-alkylpurines as adenosine receptor ligands. Bioorg Med Chem (1998) 0.88
Synergistic effects of calcium-mobilizing agents and adenosine on histamine release from rat peritoneal mast cells. Br J Pharmacol (1989) 0.87
Regulation of p42/p44 mitogen-activated protein kinase by the human adenosine A3 receptor in transfected CHO cells. Eur J Pharmacol (2001) 0.85
Pharmacological characterization of the adenylate cyclase-coupled adenosine receptor in isolated guinea pig atrial myocytes. Mol Pharmacol (1990) 0.83
Course of placental 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase mRNA expression during human gestation. Eur J Endocrinol (2001) 0.83
Signaling by extracellular nucleotides and nucleosides. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.83
Affinities of barbiturates for the GABA-receptor complex and A1 adenosine receptors: a possible explanation of their excitatory effects. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.83
Mechanism of A2 adenosine receptor activation. I. Blockade of A2 adenosine receptors by photoaffinity labeling. Mol Pharmacol (1991) 0.83
A2B adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyl adenosine and NECA derivatives. Nucleosides Nucleotides Nucleic Acids (2004) 0.82
Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists. J Med Chem (1997) 0.81
Barbiturates are selective antagonists at A1 adenosine receptors. J Neurochem (1985) 0.81
Effects of adenosine on histamine release from human lung fragments. Int Arch Allergy Immunol (1992) 0.81
Effects of temperature and membrane phase transitions on ligand binding to alpha 2-receptors of human platelets. Mol Pharmacol (1986) 0.80
Characterization of the K(+)-channel-coupled adenosine receptor in guinea pig atria. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.80
Characterization of solubilized insulin receptors from rat liver microsomes. Existence of two receptor species with different binding properties. Eur J Biochem (1986) 0.80
Synthesis of di- and tri-substituted adenosine derivatives and their affinities at human adenosine receptor subtypes. Nucleosides Nucleotides (2000) 0.80
7-Nitrobenzofurazan (NBD) derivatives of 5'-N-ethylcarboxamidoadenosine (NECA) as new fluorescent probes for human A(3) adenosine receptors. Bioorg Med Chem Lett (2001) 0.80
Reduction of postischemic leukocyte-endothelium interaction by adenosine via A2 receptor. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.79
The glycoprotein nature of A1 adenosine receptors. Biochem Biophys Res Commun (1986) 0.79
2-substituted 5'-N-methylcarboxamidoadenosine (MECA) derivatives as A3 adenosine receptor ligands. Nucleosides Nucleotides Nucleic Acids (2005) 0.79
Leukotriene B4 receptors on neutrophils in patients with psoriasis and atopic eczema. Skin Pharmacol (1989) 0.79
7-Deazaadenines bearing polar substituents: structure-activity relationships of new A(1) and A(3) adenosine receptor antagonists. J Med Chem (2000) 0.78
Adenosine regulates the Ca2+ sensitivity of mast cell mediator release. Proc Natl Acad Sci U S A (1988) 0.77
G-protein-coupled A1 adenosine receptors in coated vesicles of mammalian brain: characterization by radioligand binding and photoaffinity labelling. Cell Signal (1992) 0.77
Aza-analogs of 8-styrylxanthines as A2A-adenosine receptor antagonists. Arch Pharm (Weinheim) (1997) 0.76
Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses. Eur J Pharmacol (1991) 0.76
Radiation inactivation analysis of the A1 adenosine receptor of rat brain. Decrease in radiation inactivation size in the presence of guanine nucleotide. FEBS Lett (1989) 0.76
A carboxyl-terminal tail peptide of neutrophil chemotactic receptor disrupts its physical complex with G protein. J Leukoc Biol (1993) 0.76
Characterization of adenosine A1 receptor in a cell line (28A) derived from rabbit collecting tubule. Am J Physiol (1992) 0.76
Synthesis and receptor affinity of polysubstituted adenosines. Nucleosides Nucleotides (1999) 0.75
Defense. FASEB J (1995) 0.75
Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists. J Med Chem (1996) 0.75
[Conception and pregnancy without complications in parenteral home nutrition]. Z Geburtshilfe Perinatol (1989) 0.75
Solubilization and characterization of active neuropeptide Y receptors from rabbit kidney. J Biol Chem (1990) 0.75
[In memoriam Karl Günther Ober (24.8.1915-27.2.1999)]. Zentralbl Gynakol (2000) 0.75
[The role of mammography in the diagnosis of simultaneous second cancers in the contralateral breast]. Geburtshilfe Frauenheilkd (1988) 0.75
Characterization of [3H]phenobarbital binding to rat brain membranes. Neurosci Lett (1984) 0.75